Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2007
Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growthChibo Hong, K Scott Moorefield, Peter Jun, et al.Glia|February 5, 2011
A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic targetAlexander Schulte, Hauke S Günther, Heidi S Phillips, et al.Breast Cancer Research and Treatment|May 12, 2017
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasisGail D Lewis Phillips, Merry C Nishimura, Jennifer Arca Lacap, et al.Proceedings of the National Academy of Sciences of the United States of America|September 17, 2014
Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H gliomaRuihuan Chen, Merry C Nishimura, Samir Kharbanda, et al.Elife|August 28, 2019
Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillanceMatthew F Pech, Linda E Fong, Jacqueline E Villalta, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastomaLiliana Soroceanu, Samir Kharbanda, Ruihuan Chen, et al.Cell Reports|August 16, 2018
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 AcetylationRyan Raisner, Samir Kharbanda, Lingyan Jin, et al.Cancer Cell|March 15, 2006
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisHeidi S Phillips, Samir Kharbanda, Ruihuan Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio TrialThomas Sandmann, Richard Bourgon, Josep Garcia, et al.Cancer Research|August 19, 2017
Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate CancerLingyan Jin, Jesse Garcia, Emily Chan, et al.Pageof 2